XORTX Therapeutics Inc.
XRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729214
No open-market purchases or sales by XORTX Therapeutics Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $92.8K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding XORTX Therapeutics Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 6 | 6 | 0 |
| Shares | 101.0K | 230.7K | +129.7K (+128.4%) |
| Value | $81.5K | $123.6K | +$42.1K (+51.7%) |
New holders (3)
Institutions that held XORTX Therapeutics Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DRW Securities, LLC | 193,599 | $108.8K | 0.01% |
| Two Sigma Securities, LLC | 12,597 | $7.08K | 0.00% |
| Baader Bank INC | 18,732 | $4.74K | 0.00% |
Sold out (3)
Institutions that held XORTX Therapeutics Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Citadel Advisors LLC | 86,326 | $69.9K |
| XTX Topco Ltd | 13,820 | $11.2K |
| SBI Securities Co., Ltd. | 1 | $1 |